Escitalopram cuts MACE risk in depressed patients with ACS
(HealthDay)—For patients with depression following recent acute coronary syndrome (ACS), escitalopram results in lower risk of major adverse cardiac events (MACE) versus placebo, according to a study published in the July ...
Jul 25, 2018
0
1